Avricore Health (TSXV:AVCR) ROCE % : -29.04% (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Avricore Health ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Avricore Health's annualized ROCE % for the quarter that ended in Sep. 2024 was -29.04%.

Avricore Health ROCE % Historical Data

The historical data trend for Avricore Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avricore Health ROCE % Chart

Avricore Health Annual Data

Trend

Jun14

Jun15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-910.00

-225.22

-39.32

-35.29

Avricore Health Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-62.98	11.74	31.21	9.78	-29.04

Avricore Health ROCE % Calculation

Avricore Health's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-0.701	/	( ( (2.569 - 0.605)	+	(2.538 - 0.529) )	/ 2 )
	=	-0.701	/	( (1.964	+	2.009)	/ 2 )
	=	-0.701	/	1.9865
	=	-35.29 %

Avricore Health's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-0.692	/	( ( (2.618 - 0.341)	+	(3.024 - 0.535) )	/ 2 )
	=	-0.692	/	( ( 2.277	+	2.489 )	/ 2 )
	=	-0.692	/	2.383
	=	-29.04 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Avricore Health (TSXV:AVCR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Avricore Health ROCE % Related Terms

Thank you for viewing the detailed overview of Avricore Health's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Avricore Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Avricore Health Inc (TSXV:AVCR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

AVCRF:USA

Address

1120 - 789 West Pender Street, Vancouver, BC, CAN, V6C 1H2

Website

https://www.avricorehealth.com

Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.

Executives

Kiriaki Smith	Senior Officer
Rodger Mckendry Seccombe	Senior Officer
Alan Arnstein	Director
David Farnfield	Director
David M. Hall	Director
Inc. Emerald Health Therapeutics	10% Security Holder
Sukhwinder Singh Rai	Director

Avricore Health Headlines

No Headlines